Etoposide CAS NO. 33419-42-0

Etoposide CAS NO. 33419-42-0

Etoposide CAS NO. 33419-42-0 Etoposide for cell cycle specificity anti-tumor drugs, acting on the DNA topoisomerase Ⅱ, forming drug - enzyme - reversible complexes of DNA stability, prevent DNA repair. The compound was found to be reversible with drug clearance, allowing damaged DNA to be...
Chat Now

Product Details

Etoposide  CAS NO. 33419-42-0

Product   Name

Etoposide

 

Synonyms

9-((4,6-O-Ethylidene-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one;[5R-[5alpha,5abeta,8aalpha,9beta(R*)]]-9-[(4,6-O-Ethylidene-beta-D-glucopyranosyl)oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one;(5R,5aα,9S)-9-[[4-O,6-O-[(R)-Ethylidene]-β-D-glucopyranosyl]oxy]-5,8,8aβ,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one;Etoposide   - In combination with Cisplatin and   Bleomycin;9-((4,6-O-Ethylidine-Beta-D-Glucopyranosyl)Oxy)-;[5R-[5α,5aβ,8aα,9β(R*)]]-9-[(4,6-0-Ethylidene-α-D-glucopyransoyl)oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)furo[3',4':6,7]naptho[2,3-d]-1,3-dioxol-6-(5aH)-one;Etoposide,4′-Demethylepipodophyllotoxin   9-(4,6-O-ethylidene-β-D-glucopyranoside), VP-16-213;Etoposide

CAS   NO

33419-42-0

Appearance

white  crystalline powder

Assay

98%

MF

C29H32O13

MW

588.56

Storage   condition

Low temperature and keep dry

Capacity

10KG/month

Package  

In   Aluminum foil bags,paper drums etc.

Loading   Port

China   any port ,Beijing ,Shanghai ,Hongkong

Shipment method  

By   Sea ,Air ,Courier door to door ,etc.

Application  

Pharmaceutical   intermediate

 

 

Structure  

                                         33419-42-0

 

Etoposide  CAS NO. 33419-42-0                                                               

       Etoposide for cell cycle specificity anti-tumor drugs, acting on the DNA topoisomerase Ⅱ, forming drug - enzyme - reversible complexes of DNA stability, prevent DNA repair. The compound was found to be reversible with drug clearance, allowing damaged DNA to be repaired and reducing cytotoxicity. Therefore, prolonging the time of drug administration may improve the anti-tumor activity.


Inquiry